Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 5843702, 7 pages
https://doi.org/10.1155/2017/5843702
Research Article

Red Cell Distribution Width Is Associated with All-Cause and Cardiovascular Mortality in Patients with Diabetes

1Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
2Department of Internal Medicine, Cardiovascular Medicine/Cardiac Electrophysiology, American University of Beirut Faculty of Medicine and Medical Center, Beirut, Lebanon
3Department of Diabetes, Hamad Medical Corporation, Doha, Qatar
4Adult Cardiology, Heart Hospital, Hamad Medical Corporation, Doha, Qatar
5Department of Medicine and Genetic Medicine, Weill Cornell Medicine, Doha, Qatar

Correspondence should be addressed to Charbel Abi Khalil; ude.llenroc.dem-rataq@2202ahc

Received 1 May 2017; Accepted 27 July 2017; Published 21 November 2017

Academic Editor: Yoshifumi Saisho

Copyright © 2017 Sadeer G. Al-Kindi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Selvin, S. Marinopoulos, G. Berkenblit et al., “Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus,” Annals of Internal Medicine, vol. 141, no. 6, pp. 421–431, 2004. View at Publisher · View at Google Scholar
  2. W. B. Kannel and D. L. McGee, “Diabetes and cardiovascular disease: the framingham study,” The Journal of the American Medical Association, vol. 241, no. 19, pp. 2035–2038, 1979. View at Publisher · View at Google Scholar · View at Scopus
  3. S. M. Grundy, I. J. Benjamin, G. L. Burke et al., “Diabetes and cardiovascular disease: a statement for healthcare professionals from the american heart association,” Circulation, vol. 100, no. 10, pp. 1134–1146, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. Collaboration ERF, “Diabetes mellitus, fasting glucose, and risk of cause-specific death,” New England Journal of Medicine, vol. 2011, no. 364, pp. 829–841, 2011. View at Google Scholar
  5. N. J. Morrish, S.-L. Wang, and L. K. Stevens, “Mortality and causes of death in the WHO multinational study of vascular disease in diabetes,” Diabetologia, vol. 44, no. 2, pp. S14–S21, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. C. A. Khalil, R. Roussel, K. Mohammedi, N. Danchin, and M. Marre, “Cause-specific mortality in diabetes: recent changes in trend mortality,” European Journal of Preventive Cardiology, vol. 19, no. 3, pp. 374–381, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. R. H. Eckel, R. Kahn, R. M. Robertson, and R. A. Rizza, “Preventing cardiovascular disease and diabetes: a call to action from the american diabetes association and the american heart association,” Circulation, vol. 113, no. 25, pp. 2943–2946, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. E. S. Huang, J. B. Meigs, and D. E. Singer, “The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus,” American Journal of Medicine, vol. 111, no. 8, pp. 633–642, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. J. B. Buse and M. P. Pignone, “Primary prevention of cardiovascular diseases in people with diabetes mellitus,” Diabetes Care, vol. 30, no. 6, pp. 162–172, 2007. View at Publisher · View at Google Scholar
  10. H. M. Colhoun, D. J. Betteridge, P. N. Durrington et al., “Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (CARDS): multicentre randomised placebo-controlled trial,” The Lancet, vol. 364, no. 9435, pp. 685–696, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. P. R. Schauer, S. R. Kashyap, K. Wolski et al., “Bariatric surgery versus intensive medical therapy in obese patients with diabetes,” New England Journal of Medicine, vol. 366, no. 17, pp. 1567–76, 2012. View at Google Scholar
  12. S. Van Dieren, J. W. J. Beulens, A. P. Kengne et al., “Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review,” Heart, vol. 98, no. 5, pp. 360–369, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Cederholm, K. Eeg-Olofsson, B. Eliasson, B. Zethelius, P. M. Nilsson, and S. Gudbjörnsdottir, “Risk prediction of cardiovascular disease in type 2 diabetes,” Diabetes Care, vol. 31, no. 10, pp. 2038–2043, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. G. M. Felker, L. A. Allen, S. J. Pocock et al., “Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank,” Journal of the American College of Cardiology, vol. 50, no. 1, pp. 40–47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. L. A. Allen, G. M. Felker, M. R. Mehra et al., “Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure,” Journal of Cardiac Failure, vol. 16, no. 3, pp. 230–238, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Tonelli, F. Sacks, M. Arnold, L. Moye, B. Davis, and M. Pfeffer, “Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease,” Circulation, vol. 117, no. 2, pp. 163–168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Dabbah, H. Hammerman, W. Markiewicz, and D. Aronson, “Relation between red cell distribution width and clinical outcomes after acute myocardial infarction,” The American Journal of Cardiology, vol. 105, no. 3, pp. 312–317, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. K. Zalawadiya, V. Veeranna, A. Niraj, J. Pradhan, and L. Afonso, “Red cell distribution width and risk of coronary heart disease events,” American Journal of Cardiology, vol. 106, no. 7, pp. 988–993, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Engström, J. G. Smith, M. Persson, P. M. Nilsson, O. Melander, and B. Hedblad, “Red cell distribution width, haemoglobin A1c and incidence of diabetes mellitus,” Journal of Internal Medicine, vol. 276, no. 2, pp. 174–183, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Gang and W. Lifang, “Association of the elevated red blood cell distribution width with the risk of developing diabetes mellitus,” Internal Medicine, vol. 55, no. 15, pp. 1959–1965, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Skjelbakken, J. Lappegard, T. S. Ellingsen et al., “Red cell distribution width is associated with incident myocardial infarction in a general population: the Tromsø study,” Journal of the American Heart Association, vol. 3, no. 4, Article ID e001109, 2014. View at Publisher · View at Google Scholar
  22. Y. Arbel, D. Weitzman, R. Raz et al., “Red blood cell distribution width and the risk of cardiovascular morbidity and all-cause mortality: A population-based study,” Thrombosis and Haemostasis, vol. 111, no. 2, pp. 300–307, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Lippi, G. Targher, G. L. Salvagno, and G. C. Guidi, “Increased red blood cell distribution width (RDW) is associated with higher glycosylated hemoglobin (HbAlc) in the elderly,” Clinical Laboratory, vol. 60, no. 12, pp. 2095–2098, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. A. M. Nada, “Red cell distribution width in type 2 diabetic patients,” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 8, pp. 525–533, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Malandrino, W. C. Wu, T. H. Taveira, H. B. Whitlatch, and R. J. Smith, “Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes,” Diabetologia, vol. 55, no. 1, pp. 226–235, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. National Center for Health Statistics, Office of Analysis and Epidemiology, Public-use Linked Mortality File, 2015. Hyattsville, Maryland, 2015, http://www.cdc.gov/nchs/data_access/data_linkage/mortality.htm.
  27. A. S. Levey, L. A. Stevens, C. H. Schmid et al., “A new equation to estimate glomerular filtration rate,” Annals of Internal Medicine, vol. 150, no. 9, pp. 604–612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Schemper and T. L. Smith, “A note on quantifying follow-up in studies of failure time,” Controlled Clinical Trials, vol. 17, no. 4, pp. 343–346, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. Förhécz, T. Gombos, G. Borgulya, Z. Pozsonyi, Z. Prohászka, and L. Jánoskuti, “Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state,” The American Heart Journal, vol. 158, no. 4, pp. 659–666, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. R. D. Semba, K. V. Patel, L. Ferrucci et al., “Serum antioxidants and inflammation predict red cell distribution width in older women: the Women’s Health and Aging Study,” Clinical Nutrition, vol. 29, no. 5, pp. 600–604, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Zhang, Y. Zhang, C. Li, and L. He, “Association between red blood cell distribution and renal function in patients with untreated type 2 diabetes mellitus,” Renal Failure, vol. 37, no. 4, pp. 659–663, 2015. View at Publisher · View at Google Scholar
  32. S. Tsuboi, K. Miyauchi, T. Kasai et al., “Impact of red blood cell distribution width on long-term mortality in diabetic patients after percutaneous coronary intervention,” Circulation Journal, vol. 77, no. 2, pp. 456–461, 2013. View at Publisher · View at Google Scholar · View at Scopus